Neurocrine Biosciences Inc (NBIX) Reports Strong Growth in INGREZZA Sales for Q4 and Full Year 2023
INGREZZA Net Product Sales Surge as Company Prepares for New Drug Applications
Stay updated with breaking news from Income Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
INGREZZA Net Product Sales Surge as Company Prepares for New Drug Applications
EG's Strategic Execution Leads to Historic Profitability and Shareholder Returns
/PRNewswire/ -- Grupo Rotoplas S.A.B. de C.V. (BMV: AGUA*) ("Rotoplas", "the Company"), America's leading company in water solutions, reports its unaudited...
True, the path to homeownership will be bumpier, but these tips can help you navigate it.
Fourth Quarter 2023 Highlights Total revenues of $821.9 million, down 5% Operating income of $37.9 million, down 57%; non-GAAP adjusted operating income of $39.2 million, down 56% Operating...